Effect of HIV and/or Active Tuberculosis on the Humoral and Cell Mediated Immune Responses to Un-adjuvanted Trivalent Sub-unit Influenza Vaccine (TIV) in Adults
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications HIV infections; Tuberculosis
- Focus Pharmacodynamics
- 05 Sep 2018 Biomarkers information updated
- 10 Dec 2013 Planned End Date changed from 1 Dec 2013 to 1 Dec 2014 as reported by ClinicalTrials.gov.
- 10 Dec 2013 Planned initiation date changed from 1 Mar 2013 to 1 Mar 2014 as reported by ClinicalTrials.gov.